Bacteria Combination

Adenosinum Triphosphoricum Dinatrum, Malicum Acidum, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Cinnamic Acid, Petroselinum Sativum, Colibacillinum Cum Natrum Muriaticum, Echinacea (angustifolia), Helicobacter Pylori, Mycoplasma Pneumoniae, Proteus (mirabilis), Proteus (vulgaris), Pseudomonas Aeruginosa, Salmonella Typhi Nosode, Enterococcus Faecalis, Streptococcus Mutans, Pneumococcinum, Streptococcus Agalactiae, Legionella Pneumophila, Listeria Monocytogenes, Dysentery Bacillus, Shigella Sonnei,

Deseret Biologicals, Inc.
Human Otc Drug
NDC 43742-1587

Bacteria Combination also known as Adenosinum Triphosphoricum Dinatrum, Malicum Acidum, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Cinnamic Acid, Petroselinum Sativum, Colibacillinum Cum Natrum Muriaticum, Echinacea (angustifolia), Helicobacter Pylori, Mycoplasma Pneumoniae, Proteus (mirabilis), Proteus (vulgaris), Pseudomonas Aeruginosa, Salmonella Typhi Nosode, Enterococcus Faecalis, Streptococcus Mutans, Pneumococcinum, Streptococcus Agalactiae, Legionella Pneumophila, Listeria Monocytogenes, Dysentery Bacillus, Shigella Sonnei, is a human otc drug labeled by 'Deseret Biologicals, Inc.'. National Drug Code (NDC) number for Bacteria Combination is 43742-1587. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Bacteria Combination drug includes Adenosine Phosphate Disodium - 6 [hp_X]/mL Cinnamic Acid - 6 [hp_X]/mL Echinacea Angustifolia - 15 [hp_X]/mL Enterococcus Faecalis - 13 [hp_C]/mL Escherichia Coli - 15 [hp_X]/mL Helicobacter Pylori - 15 [hp_X]/mL Legionella Pneumophila - 14 [hp_C]/mL Listeria Monocytogenes - 14 [hp_C]/mL Malic Acid - 6 [hp_X]/mL Mycoplasma Pneumoniae - 15 [hp_X]/mL and more. The currest status of Bacteria Combination drug is Active.

Drug Information:

Drug NDC:	43742-1587
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Bacteria Combination
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Adenosinum Triphosphoricum Dinatrum, Malicum Acidum, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Cinnamic Acid, Petroselinum Sativum, Colibacillinum Cum Natrum Muriaticum, Echinacea (angustifolia), Helicobacter Pylori, Mycoplasma Pneumoniae, Proteus (mirabilis), Proteus (vulgaris), Pseudomonas Aeruginosa, Salmonella Typhi Nosode, Enterococcus Faecalis, Streptococcus Mutans, Pneumococcinum, Streptococcus Agalactiae, Legionella Pneumophila, Listeria Monocytogenes, Dysentery Bacillus, Shigella Sonnei,
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Deseret Biologicals, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ADENOSINE PHOSPHATE DISODIUM - 6 [hp_X]/mL CINNAMIC ACID - 6 [hp_X]/mL ECHINACEA ANGUSTIFOLIA - 15 [hp_X]/mL ENTEROCOCCUS FAECALIS - 13 [hp_C]/mL ESCHERICHIA COLI - 15 [hp_X]/mL HELICOBACTER PYLORI - 15 [hp_X]/mL LEGIONELLA PNEUMOPHILA - 14 [hp_C]/mL LISTERIA MONOCYTOGENES - 14 [hp_C]/mL MALIC ACID - 6 [hp_X]/mL MYCOPLASMA PNEUMONIAE - 15 [hp_X]/mL Load more... OROTIC ACID MONOHYDRATE - 6 [hp_X]/mL PETROSELINUM CRISPUM - 6 [hp_X]/mL PROTEUS MIRABILIS - 15 [hp_X]/mL PROTEUS MORGANII - 30 [hp_C]/mL PROTEUS VULGARIS - 15 [hp_X]/mL PSEUDOMONAS AERUGINOSA - 15 [hp_X]/mL RIBOFLAVIN - 6 [hp_X]/mL SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI - 17 [hp_X]/mL SHIGELLA DYSENTERIAE - 15 [hp_C]/mL SHIGELLA SONNEI - 15 [hp_C]/mL SODIUM DIETHYL OXALACETATE - 6 [hp_X]/mL STREPTOCOCCUS AGALACTIAE - 14 [hp_C]/mL STREPTOCOCCUS DYSGALACTIAE - 15 [hp_C]/mL STREPTOCOCCUS EQUINUS - 15 [hp_C]/mL STREPTOCOCCUS MUTANS - 13 [hp_C]/mL STREPTOCOCCUS PNEUMONIAE - 13 [hp_C]/mL STREPTOCOCCUS UBERIS - 32 [hp_C]/mL STREPTOCOCCUS VIRIDANS GROUP - 38 [hp_C]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	18 Nov, 2019
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	20 Jul, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	07 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Deseret Biologicals, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	T1WZ11DSRN U14A832J8D VB06AV5US8 15E04LZ9CT 514B9K0L10 U09W5JOL3Z TJR6ZFY0F0 3O44K14A86 817L1N4CKP JQE470FAD0 Load more... 91532S02AO 1WZA4Y92EX C177VR41DV 56X6LID5ZY 11T9HCO30O Y793W5V55N TLM2976OFR 760T5R8B3O 1EP6R5562J OO358E3009 6CA025Y4FG 2B3763S671 LN0SH02Y5M R2P4NKP3ZK 5C7J33MJJ1 BT6U234YR2 O84V4ZK4BX NNV2379HKR
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
43742-1587-1	30 mL in 1 BOTTLE, DROPPER (43742-1587-1)	18 Nov, 2019	20 Jul, 2025	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Adenosinum Triphosphoricum Dinatrum & more..

Liquid
Deseret Biologicals, Inc.
NDC: 43742-1698

Bacteria Combination

Adenosinum Triphosphoricum Dinatrum & more..

Liquid
Deseret Biologicals, Inc.
NDC: 43742-1587

Purpose:

Homeopathic indications: for the temporary relief of symptoms related to common bacterial infections (respiratory and urinary tract infections, food poisoning) such as fever, headache, mucous congestion, stomach discomfort, cough, joint discomfort, and occasional diarrhea.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Product Elements:

Bacteria combination adenosinum triphosphoricum dinatrum, malicum acidum, natrum oxalaceticum, oroticum acidum, riboflavinum, cinnamic acid, petroselinum sativum, colibacillinum cum natrum muriaticum, echinacea (angustifolia), helicobacter pylori, mycoplasma pneumoniae, proteus (mirabilis), proteus (vulgaris), pseudomonas aeruginosa, salmonella typhi nosode, enterococcus faecalis, streptococcus mutans, pneumococcinum, streptococcus agalactiae, legionella pneumophila, listeria monocytogenes, dysentery bacillus, shigella sonnei, adenosine phosphate disodium adenosine phosphate malic acid malic acid sodium diethyl oxalacetate diethyl oxalacetate orotic acid monohydrate orotic acid riboflavin riboflavin cinnamic acid cinnamic acid petroselinum crispum petroselinum crispum escherichia coli escherichia coli echinacea angustifolia echinacea angustifolia helicobacter pylori helicobacter pylori mycoplasma pneumoniae mycoplasma pneumoniae proteus mirabilis proteus mirabilis proteus vulgaris proteus vulgaris pseudomonas aeruginosa pseudomonas aeruginosa salmonella enterica enterica serovar typhi salmonella enterica enterica serovar typhi enterococcus faecalis enterococcus faecalis streptococcus mutans streptococcus mutans streptococcus pneumoniae streptococcus pneumoniae streptococcus agalactiae streptococcus agalactiae legionella pneumophila legionella pneumophila listeria monocytogenes listeria monocytogenes shigella dysenteriae shigella dysenteriae shigella sonnei shigella sonnei streptococcus dysgalactiae streptococcus dysgalactiae proteus morganii proteus morganii streptococcus equinus streptococcus equinus streptococcus uberis streptococcus uberis streptococcus viridans group streptococcus viridans group water alcohol

Indications and Usage:

Warnings:

Warnings: keep out of reach of children. in case of overdose, contact a physician or poison control center right away. if pregnant or breast-feeding, ask a health professional before use. tamper seal: "sealed for your protection." do not use if seal is broken or missing.

Dosage and Administration:

Directions: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. consult a physician for use in children under 12 years of age.

Package Label Principal Display Panel:

Package label display: des bio ndc 43742-1587-1 homeopathic bacteria combination 1 fl oz (30 ml) bacteria combination

Further Questions:

Questions: dist. by: deseret biologicals, inc. 469 w. parkland drive sandy, ut 84070 www.desbio.com

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.